Cardiac-specific transgenic overexpression of α1B- adrenergic receptors induce chronic activation of ERK MAPK signalling

Biochemistry and Cell Biology

Volumn 82, Issue 6, 2004, Pages 719-727

  Benoit, Marie Josée ^a,b   Rindt, Hansjörg ^c   Allen, Bruce G ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c Myogen Inc   (United States)

Author keywords

Adrenergic receptor; Cell communication; ERK; Heart; MCIP1; MKP; Signal transduction

Indexed keywords

BIOCHEMISTRY; CARDIOLOGY; CYTOLOGY; ENZYMES; PROTEINS; RNA; SIGNALING;

CARDIOMYOPATHY; EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK); MODULATORY CALCINEURIN-INTERACTING PROTEIN (MCIP); PHOSPHORYLATION;

ENZYME KINETICS;

ALPHA 1B ADRENERGIC RECEPTOR; CALCINEURIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 2; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 3; PROTEIN; PROTEIN MCIP 1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; CARDIOMYOPATHY; CELL COMMUNICATION; CONFERENCE PAPER; CONTROLLED STUDY; DEATH; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HEART FAILURE; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE PROTEINS; MYOCARDIUM; PHOSPHOPROTEIN PHOSPHATASE; RECEPTORS, ADRENERGIC, ALPHA-1; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA;

EID: 16844372360     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o04-123     Document Type: Conference Paper

References (55)

1. 2α in cultured neonatal rat ventricular myocytes. Circ. Res. 83: 167-178.
2. Aoki, H., Richmond, M., Izumo, S., and Sadoshima, J. 2000. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem. J. 347: 275-284.
3. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
4. Bush, E., Fielitz, J., Melvin, L., Martinez-Arnold, M., Mckinsey, T.B., Plichta, R., and Olson, E.N. 2004. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc. Natl. Acad. Sci. USA, 101: 2870-2875.
5. Camps, M., Nichols, A., and Arkinstall, S. 2000. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J. 14: 6-16.
6. Chalothorn, D., Mccune, D.F., Edelmann, S.E., Garcia-Cazarin, M.L., Tsujimoto, G., and Piascik, M.T. 2002. Differences in the cellular localization and agonist-mediated internalization properties of the alpha,-adrenoceptor subtypes. Mol. Pharmacol. 61: 1008-1016.
7. Clerk, A., Gillespie-Brown, J., Fuller, S.J., and Sugden, P.H. 1996. Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochem. J. 317: 109-118.
8. De Windt, L.J., Lim, H.W., Bueno, O.F., Liang, Q., Delling, U., Braz, J.C. et al. 2001. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA, 98: 3322-3327.
9. Farooq, A., and Zhou, M.M. 2004. Structure and regulation of MAPK phosphatases. Cell. Signal. 16: 769-779.
10. Fedida, D., Braun, A.P., and Giles, W.R. 1993. Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms. Physiol. Rev. 73: 469-487.
11. Fuller, S.J., Davies, E.L., Gillespie-Brown, J., Sun, H., and Tonks, N.K. 1997. Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes. Biochem. J. 323: 313-319.
12. Gillespie-Brown, J., Fuller, S.J., Bogoyevitch, M.A., Cowley, S., and Sugden, P.H. 1995. The mitogen-activated protein kinase kinase MEK1 stimulates a pattern of gene expression typical of the hypertrophic phenotype in rat ventricular cardiomyocytes. J. Biol. Chem. 270: 28 092-28 096.
13. Glennon, P.E., Kaddoura, S., Sale, E.M., Sale, G.J., Fuller, S.J., and Sugden, P.H. 1996. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ. Res. 78: 954-961.
14. 1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am. J. Physiol. 275: H1338-H1350.
15. Harris, I.S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., and Muslin, A.J. 2004. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload. Circulation, 110: 718-723.
16. Keyse, S.M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12: 186-192.
17. 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268: 15 374-15 380.
18. 1BAR regulates βAR activity via molecular crosstalk. J. Mol. Cell. Cardiol. 30: 1827-1839.
19. 1B-AR induces dilated cardiomyopathy. Am. J. Physiol. 281: H931-H938.
20. Lipkin, G.W., Tucker, B., Giles, M., and Raine, A.E. 1993. Ambulatory blood pressure and left ventricular mass in cyclosporin- and non-cyclosporin-treated renal transplant recipients. J. Hypertens. 11: 439-442.
21. Meidell, R.S., Sen, A., Henderson, S.A., Slahetka, M.F., and Chien, K.R. 1986. Alpha 1-adrenergic stimulation of rat myocardial cells increases protein synthesis. Am. J. Physiol. 251: H1076-H1084.
22. 1-adrenoceptor subtypes in rat heart. Br. J. Pharmacol. 111: 533-538.
23. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA, 91: 10109-10113.
24. Minneman, K.P., and Esbenshade, T.A. 1994. Alpha 1-adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 34: 117-133.
25. Minneman, K.P., Theroux, T.L., Hollinger, S., Han, C., and Esbenshade, T.A. 1994. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol. Pharmacol. 46: 929-936.
26. Molkentin, J.D. 2004. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc. Res. 63: 467-475.
27. Molkentin, J.D., Lu, J.R., Antos, C.L., Markham, B., Richardson, J., Robbins, J. et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93: 215-228.
28. Neel, B.G., and Tonks, N.K. 1997. Protein tyrosine phosphatases in signal transduction. Curr. Opin. Cell Biol. 9: 193-204.
29. Nemoto, S., Sheng, Z., and Lin, A. 1998. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18: 3518-3526.
30. 1B- adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Investig. 111: 1783-1791.
31. Olson, E.N., and Williams, R.S. 2000a. Calcineurin signaling and muscle remodeling. Cell, 101: 689-692.
32. Olson, E.N., and Williams, R.S. 2000b. Remodeling muscles with calcineurin. Bioessays, 22: 510-519.
33. Post, G.R., Goldstein, D., Thuerauf, D.J., Glembotski, C.C., and Brown, J.H. 1996. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J. Biol. Chem. 271: 8452-8457.
34. 1C. J. Biol. Chem. 271: 5839-5843.
35. Rothermel, B., Vega, R.B., Yang, J., Wu, H., Bassel-Duby, R., and Williams, R.S. 2000. A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J. Biol. Chem. 275: 8719-8725.
36. Rothermel, B.A., Mckinsey, T.A., Vega, R.B., Nicol, R.L., Mammem, P., Yang, J. et al. 2001. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc. Natl. Acad. Sci. USA, 98: 3328-3333.
37. Rothermel, B.A., Vega, R.B., and Williams, R.S. 2003. The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc. Med. 13: 15-21.
38. 2+-dependent PKC isoforms unmasks ERK-dependent hypertrophic growth evoked by phenylephrine in adult ventricular cardiomyocytes. Cardiovasc. Res. 63: 553-560.
39. Sheng, Z., Knowlton, K., Chen, J., Hoshijima, M., Brown, J.H., and Chien, K.R. 1997. Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272: 5783-5791.
40. Silberbach, M., Gorenc, T., Hershberger, R.E., Stork, P.J., Steyger, P.S., and Roberts, C.T., Jr. 1999. Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274: 24 858-24 864.
41. 1-adrenergic response. J. Clin. Investig. 72: 732-738.
42. 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. Circ. Res. 56: 884-894.
43. Steinmetz, R., Wagoner, H.A., Zeng, P., Hammond, J.R., Hannon, T.S., Meyers, J.L., and Pescovitz, O.H. 2004. Mechanisms Regulating the Constitutive Activation of the ERK Signaling Pathway in Ovarian Cancer and the Effect of RNAi for ERK1/2 on Cancer Cell Proliferation. Mol. Endocrinol. 18: 2570-2582.
44. Stewart, A.F., Rokosh, D.G., Bailey, B.A., Karns, L.R., Chang, K.C., Long, C.S. et al. 1994. Cloning of the rat alpha 1C-adrenergic receptor from cardiac myocytes, alpha 1C, alpha 1B, and alpha 1D mRNAs are present in cardiac myocytes but not in cardiac fibroblasts. Circ. Res. 75: 796-802.
45. Thorburn, J., Frost, J.A., and Thorburn, A. 1994. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126: 1565-1572.
46. Ueyama, T., Kawashima, S., Sakoda, T., Rikitake, Y., Ishida, T., Kawai, M. et al. 2000. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J. Mol. Cell. Cardiol. 32: 947-960.
47. van Rooij, E., Doevendans, P.A., Crijns, H.J.G.M., Heeneman, S., Lips, D.J., Van Bilsen et al. 2004. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ. Res. 94: e18-e26.
48. Vecchione, C., Fratta, L., Rizzoni, D., Notte, A., Poulet, R., Porteri, E. et al. 2002. Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation, 105: 1700-1707.
49. Vega, R.B., Rothermel, B.A., Weinheimer, C.J., Kovacs, A., Naseem, R.H., Bassel-Duby, R. et al. 2003. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc. Natl. Acad. Sci. USA, 100: 669-674.
50. Wang, Z., Yue, L., White, M., Pelletier, G., and Nattel, S. 1998. Differential distribution of inward rectifier potassium channel transcripts in human atrium versus ventricule. Circulation, 98: 2422-2428.
51. 1-adrenoreceptor subtypes to phospholipase C and mitogen activated protein kinase in neonatal rat cardiac myocytes. Eur. J. Pharmacol. 339: 77-86.
52. Williamson, D., Gallagher, P., Harber, M., Hollon, C., and Trappe, S. 2003. Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle. J. Physiol. 547: 977-987.
53. Yang, J., Rothermel, B., Vega, R.B., Frey, N., Mckinsey, T.A., Olson, E.N. et al. 2000. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ. Res. 87: 61e-68e.
54. Zhong, H., and Minneman, K.P. 1999. α1-Adrenergic subtypes. Eur. J. Pharmacol. 375: 261-276.
55. 1B-adrenergic receptor. J. Biol. Chem. 276: 13 738-13 743.